Intersect Ent Inc
F:7IN
Relative Value
There is not enough data to reliably calculate the relative value of 7IN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
7IN Competitors Multiples
Intersect Ent Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
I
|
Intersect Ent Inc
F:7IN
|
912.9m EUR | 10.3 | -6.4 | -15.8 | -15 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
197B USD | 4.4 | 30.2 | 17.3 | 23.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.9B USD | 17.7 | 62.4 | 47.4 | 58.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
147B USD | 5.8 | 45.2 | 22.9 | 27.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
122.8B USD | 3.5 | 26.7 | 14.5 | 21.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 5.4 | 37.3 | 21.8 | 29.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.8B EUR | 2 | 22.2 | 12.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.1B USD | 12 | 48.8 | 34.6 | 38.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49B USD | 2.2 | 27.7 | 10.7 | 18.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.7B USD | 8.2 | 46.3 | 25.5 | 28 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.5B USD | 7 | 25.3 | 17.9 | 19.9 |